BioSpace News Archive

Battelle is funding the Ohio STEM Learning Network’s grant program to foster sustainable STEM education programming in classrooms and schools in Ohio.

AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability

Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia” or the “Company”) is pleased to provide its financial results for the year ended March 31, 2023.

MEKanistic Therapeutics announced today that its investigational cancer clinical candidate MTX-531 has been approved for receiving continued development support from the National Cancer Institute’s (NCI) Experimental Therapeutics (NExT) Program.

RevBio has Developed a More Rapidly Resorbing Formulation of its Bone Adhesive Biomaterial for Implant Dentistry which will be Used in this Study.

RegeneRx Biopharmaceuticals, Inc. announced that, pursuant to the company’s consent solicitation dated July 11, 2023, holders of 48.5% of the Company’s outstanding stock have voted to date, with 94% voting in favor of the proposed reverse stock split.

Plandai Biotechnology, Inc. announces the rescission of a material definitive agreement with Good Salt, LLC due to the material failure of consideration in the transaction.

Pyxis Oncology, Inc., a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, announced that Lara S. Sullivan, M.D., President and Chief Executive Officer, will present a company overview at the BTIG Virtual Biotechnology Conference on August 7, 2023 at 3:00 PM EST.

Y-mAbs Therapeutics, Inc. announced that it will report its financial results for the second quarter ended June 30, 2023, on Thursday, August 10, 2023, after the close of the U.S. financial markets.

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report second quarter 2023 financial results and corporate highlights after the U.S. financial markets close on Tuesday, August 8, 2023.